Related Experiment Video
Updated: Aug 15, 2026
06:02
Microiontophoresis and Micromanipulation for Intravital Fluorescence Imaging of the Microcirculation
Published on: June 10, 2011
Potential novel methods for insulin administration: I. Iontophoresis
Biomedica Biochimica Acta
|January 1, 1984
Summary
Transcutaneous insulin delivery via iontophoresis was unsuccessful with conventional insulin but feasible with a modified, ionized form in animal models. This research explores novel methods for transdermal hormone administration.
Area of Science:
- Endocrinology
- Pharmacology
- Biomedical Engineering
Background:
- Transcutaneous drug delivery aims to bypass first-pass metabolism.
- Iontophoresis utilizes electric current to enhance transdermal solute transport.
- Conventional insulin formulations present challenges for iontophoretic delivery due to ionization state and aggregation.
Purpose of the Study:
- To investigate the feasibility of transcutaneous insulin administration using iontophoresis.
- To identify insulin properties amenable to iontophoretic delivery.
- To evaluate the efficacy of iontophoresis for delivering modified insulin in an animal model.
Main Methods:
- Human volunteers attempted transcutaneous delivery of conventional insulin via iontophoresis.
- Pigs underwent experiments to characterize insulin pharmacokinetics following different administration routes (native secretion, intraperitoneal, intramuscular).
- Transcutaneous iontophoretic delivery of a modified, ionized insulin form was tested in an experimental animal model.
Main Results:
- Iontophoretic delivery of conventional insulin in humans was unsuccessful.
- Animal studies established baseline insulin concentration profiles for various delivery methods.
- Successful transcutaneous administration of a modified, ionized insulin form was achieved in an animal model.
Conclusions:
- Conventional insulin's properties (weak ionization, polymeric form) hinder iontophoretic delivery.
- A modified, more strongly ionized, and monomeric insulin form enables transcutaneous delivery via iontophoresis.
- This study demonstrates the potential of iontophoresis for delivering modified insulin transcutaneously in experimental settings.
Related Concept Videos
01:25Routes of Drug Administration: Parenteral
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:25Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...